Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 573,171 | 561,691 | 574,962 | 579,605 | 580,176 |
| Receivables | 39,259 | 39,529 | 54,605 | 49,202 | 49,219 |
| Inventories | 49,294 | 49,846 | 51,397 | 49,142 | 47,402 |
| Other current assets | 6,575 | 0 | 0 | 0 | 0 |
| TOTAL | $685,362 | $667,884 | $699,912 | $700,865 | $699,312 |
| Non-Current Assets | |||||
| PPE Net | 165,503 | 161,628 | 162,900 | 153,565 | 141,619 |
| Intangibles | 533,278 | 540,147 | 547,016 | 553,885 | 561,185 |
| Other Non-Current Assets | 63,465 | 74,982 | 77,622 | 859,238 | 862,321 |
| TOTAL | $762,246 | $776,757 | $787,538 | $1,566,688 | $1,565,125 |
| Total Assets | $1,447,608 | $1,444,641 | $1,487,450 | $2,267,553 | $2,264,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 5,440 | 5,440 | 5,440 | 5,440 |
| Accounts payable and accrued liabilities | 12,536 | 8,226 | 10,729 | 9,424 | 6,658 |
| Accrued Expenses | 40,719 | 35,405 | 60,237 | 56,042 | 50,344 |
| TOTAL | $68,552 | $59,022 | $87,468 | $78,253 | $74,919 |
| Non-Current Liabilities | |||||
| Long Term Debt | 517,083 | 517,893 | 518,707 | 519,520 | 520,336 |
| Deferred Revenues | 2,078 | 2,210 | 3,360 | 2,553 | 2,459 |
| Other Non-Current Liabilities | 62,663 | 69,225 | 63,517 | 747,372 | 736,198 |
| TOTAL | $602,642 | $608,230 | $610,098 | $1,297,019 | $1,291,880 |
| Total Liabilities | $671,194 | $667,252 | $697,566 | $1,375,272 | $1,366,799 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 252,237 | 251,925 | 251,400 | 251,283 | 251,018 |
| Common Shares | 2,522 | 2,518 | 2,513 | 2,510 | 2,510 |
| Retained earnings | 266,074 | 273,659 | 285,737 | 391,696 | 398,158 |
| Other shareholders' equity | 339,481 | 366,730 | 373,131 | 372,987 | 377,067 |
| TOTAL | $776,414 | $777,389 | $789,884 | $892,281 | $897,638 |
| Total Liabilities And Equity | $1,447,608 | $1,444,641 | $1,487,450 | $2,267,553 | $2,264,437 |